Ono Pharmaceutical Co., Ltd. ( OPHLY) - Key Metrics
OPHLY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $83.48 | $17.36 | $0.76 | -$0.67 |
| 2026Q4 | $85.82 | $0.59 | $36.06 | $35.34 |
| 2026Q3 | $101.03 | $20.84 | $23.44 | $22.71 |
| 2026Q2 | $93.55 | $16.24 | $37.54 | $36.33 |
| 2026Q1 | $90.40 | $12.53 | $2.39 | $0.80 |
OPHLY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 72.32% | 11.10 |
| 2026Q4 | 27.71% | 354.41 |
| 2026Q3 | 62.67% | 8.56 |
| 2026Q2 | 5.85% | 8.73 |
| 2026Q1 | 98.43% | 10.25 |
OPHLY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q1 | -0.09% | 1.59% |
| 2026Q4 | 4.23% | 0.02% |
| 2026Q3 | 3.18% | 1.83% |
| 2026Q2 | 6.50% | 0.17% |
| 2026Q1 | 0.15% | 2.40% |
OPHLY
Price: $5.17
52 week price:
Dividend Yield: 3.49%
Payout Ratio Range:
Earnings Per Share: 0.31 USD
P/E Ratio: 15.55
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 6.8 billion